薄肾小球基底膜表型中未发现致病性COL4A3/A4/A5变异
该回顾性研究筛查两家美国医疗中心接受肾活检且有385个肾病基因大panel检测结果的患者,分析GBM厚度、eGFR、蛋白尿和血尿与基因型的关联。115例中49例有GBM超微结构异常,其中仅9例携带COL4A基因P/LP变异,31例薄GBM为野生型。结论:近三分之二薄GBM患者无COL4A3/A4/A5变异,基因检测可能不能替代肾活检。
要点
- 薄GBM患者中近2/3无COL4A3/A4/A5基因变异。
- COL4A基因P/LP变异仅与GBM厚度相关,与其他临床指标无关。
- 基因检测可能不能替代肾活检,薄GBM仍需组织病理评估。
核心结论
- 近三分之二薄GBM患者无COL4A3/A4/A5基因变异,基因检测可能不能替代肾活检。
研究设计与样本
- 回顾性基因型-表型关联研究,筛查两家美国医疗中心接受肾活检且有385个肾病基因大panel检测结果的患者,共115例。
主要发现
- 115例中49例有GBM超微结构异常,其中9例携带COL4A基因P/LP变异,9例携带VUS,31例薄GBM为COL4A3/A4/A5野生型。
- 1例COL4A4 P变异患者无GBM异常;3个COL4A VUS经实验检测升级为P/LP。
- COL4A基因P/LP变异与GBM厚度相关,但与eGFR、蛋白尿、血尿等其他临床参数无关。
- 31例无COL4A变异的薄GBM病例中,发现SRNS、CAKUT和ADTKD基因的P/LP或高风险VUS变异。
- 薄GBM活检标本中免疫介导肾小球损伤的发生率与正常GBM标本相当。
临床怎么用
- 薄GBM表型患者应结合肾活检病理与基因检测综合评估,不应仅凭基因panel阴性排除Alport相关肾病。
- 对无COL4A变异的薄GBM患者,需关注SRNS、CAKUT、ADTKD相关基因变异及免疫介导肾小球损伤。
局限性
- 回顾性研究,样本来自两家医疗中心,样本量有限。
- 仅纳入同时有肾活检和基因检测数据的患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Pathogenic (P) variants in COL4A3/A4/A5 genes are known to cause thin glomerular basement membrane (GBM) or Alport-related kidney disease; however, the exact diagnostic yield of genetic testing remains unknown. METHODS: In this retrospective genotype-phenotype correlation study, we screened the patient populations of 2 major US medical centers for individuals who underwent kidney biopsy, and who had documented genetic testing results on a large 385-kidney disease gene panel. We correlated GBM thickness, estimated glomerular filtration rate, proteinuria, and hematuria with genotyping results. RESULTS: We identified 115 patients with coexisting histopathology and genetic testing data, of which 49 had ultrastructural abnormalities of the GBM. Among those 49 cases, 9 had a heterozygous pathogenic or likely pathogenic (P/LP) variant in one of the COL4A genes, and 9 additional patients had COL4A variants of uncertain significance (VUS). Thirty-one patients with thin GBM were COL4A3/A4/A5 wildtype. One patient with a P variant in COL4A4 had no GBM abnormalities. Three COL4A VUS were upgraded to P/LP through experimental testing. Presence of P/LP variants in COL4A genes correlated with GBM thickness, but not with other clinical parameters. Among 31 thin GBM cases with no COL4A variant, we found variants in steroid-resistant nephrotic syndrome-, congenital anomalies of the kidneys and urinary tract (CAKUT)-, and autosomal dominant tubulointerstitial kidney disease (ADTKD) genes characterized as P/LP or as "high-risk VUS." Immune-mediated glomerular injury was as frequent in biopsy specimens with thin GBM as with normal GBM. CONCLUSION: In our study, almost two-thirds of patients with thin GBM have no variant in COL4A3/A4/A5 genes. Our data suggest that genetic testing may not obviate the need for kidney biopsy.
引用
- Riella CV, Colombo DA, Rennke HG, et al. Thin Glomerular Basement Membrane Phenotypes With No Identified Pathogenic COL4A3/A4/A5 Variant. Kidney Int Rep. 2026. PMID: 42254847. doi:10.1016/j.ekir.2026.106548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。